ScholarIQanswers from OpenAlex & ORCID
Chao‐Chi Ho
ResearcherPublications, citations & collaboration network
Chao‐Chi Ho is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Chao‐Chi Ho have?
ScholarIQindexed works
Chao‐Chi Ho has 204 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Chao‐Chi Ho have?
ScholarIQcitation count
Chao‐Chi Ho has 5,823 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Chao‐Chi Ho?
ScholarIQh-index
Chao‐Chi Ho has an h-index of 37 in OpenAlex.
What is the i10-index of Chao‐Chi Ho?
ScholarIQi10-index
Chao‐Chi Ho has an i10-index of 102 in OpenAlex.
What is the OpenAlex record for Chao‐Chi Ho?
ScholarIQopenalex
The OpenAlex for Chao‐Chi Ho is on the source record.
What are the most-cited papers on Chao‐Chi Ho?
ScholarIQmost cited works
Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling
Wan-Jiun Chen, Chao‐Chi Ho, Yih‐Leong Chang, Hsuan‐Yu Chen, Hsuan-Yu Chen, Thai‐Yen Ling, Thai‐Yen Ling, Shinsheng Yuan, Shin-Sheng Yuan, Yu-Ju Louisa Chen, Chien-Yu Lin, Szu‐Hua Pan, Han‐Yi Chou, Yu‐Ju Chen, Gee-Chen Chang, Wen-Cheng Chu, Jen‐Yi Lee, Pei-Jung Lee, Pei-Jung Lee, Ker-Chau Li, Huei‐Wen Chen, Huei‐Wen Chen, Pan‐Chyr Yang
Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression
Ang Yuan, Yi‐Jing Hsiao, Hsuan‐Yu Chen, Huei‐Wen Chen, Chao‐Chi Ho, Yu-Yun Chen, Yi-Chia Liu, Tsai-Hsia Hong, Sung‐Liang Yu, Jeremy J.W. Chen, Pan‐Chyr Yang
Up-Regulated Caveolin-1 Accentuates the Metastasis Capability of Lung Adenocarcinoma by Inducing Filopodia Formation
Chao‐Chi Ho, Pei‐Hsin Huang, Hsin‐Yi Huang, Yen-Ho Chen, Pan‐Chyr Yang, Su-Ming Hsu
Curcumin Inhibits Lung Cancer Cell Invasion and Metastasis through the Tumor Suppressor HLJ1
Huei‐Wen Chen, Jen‐Yi Lee, Jiying Huang, Chi‐Chuan Wang, Wan-Jiun Chen, Sheng‐Fang Su, Chia-Wen Huang, Chao‐Chi Ho, Jeremy J.W. Chen, Meng‐Feng Tsai, Sung‐Liang Yu, Pan‐Chyr Yang
Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib
Chao‐Chi Ho, Wei‐Yu Liao, Chih-An Lin, Jin‐Yuan Shih, Chong‐Jen Yu, James Chih‐Hsin Yang